Status:
COMPLETED
FR in Stored Plasma
Lead Sponsor:
Royal Marsden NHS Foundation Trust
Collaborating Sponsors:
Institute of Cancer Research, United Kingdom
Conditions:
Ovarian Cancer
Eligibility:
FEMALE
Brief Summary
The folate receptor (FR) is a cell over expressed on the surface of certain cancers, this occurs most frequently in ovarian cancers. Some normal tissues also express the FR, however in these normal ti...
Detailed Description
FR may be released from the cancer cells in the blood. We have developed a method in the laboratory which has been able to measure the FR obtained from cancer cells in culture which has been added int...
Eligibility Criteria
Inclusion
- Patients with ovarian cancer who have given informed consent to have blood collected for the plasma bank in the 'Pharmacogenetics and proteomics studies in patients receiving novel anticaner agents' study.
Exclusion
- Patients who have withdrawn consent form their blood stored within the 'Pharmacogenetics and proteomics studies in patients receiving novel anticancer agents' study to be used for research.
Key Trial Info
Start Date :
July 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 1 2011
Estimated Enrollment :
27 Patients enrolled
Trial Details
Trial ID
NCT00787514
Start Date
July 1 2008
End Date
February 1 2011
Last Update
May 23 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Royal Marsden NHS Foundation Trust
Sutton, Surrey, United Kingdom, SM2 5PT